CYP2C9*3 allelic variant is associated with metabolism of irbesartan in Chinese population.

European journal of clinical pharmacology

Volumn 61, Issue 9, 2005, Pages 627-634

  Hong, Xiumei ^a   Zhang, Shanchun ^a   Mao, Guangyun ^a   Jiang, Shanqun ^a   Zhang, Yan ^a   Yu, Yunxian ^a   Tang, Genfu ^a   Xing, Houxun ^a   Xu, Xiping ^a  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BIPHENYL DERIVATIVE; CYP2C9 PROTEIN, HUMAN; IRBESARTAN; TETRAZOLE DERIVATIVE; UNSPECIFIC MONOOXYGENASE;

ADULT; ALLELE; ARTICLE; ASIAN; CLINICAL TRIAL; ENZYMOLOGY; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; HYPERTENSION; MALE; METABOLISM; MIDDLE AGED; ORAL DRUG ADMINISTRATION; STATISTICAL MODEL;

ADMINISTRATION, ORAL; ADULT; ALLELES; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ARYL HYDROCARBON HYDROXYLASES; ASIAN CONTINENTAL ANCESTRY GROUP; BIPHENYL COMPOUNDS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; HYPERTENSION; LINEAR MODELS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; TETRAZOLES;

EID: 33645340776     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-005-0976-8     Document Type: Article

References (0)